About the Event

Quality. Speed. Cost. Reliability. Experience. All factors that make Australia a sought after and highly regarded destination for early phase trials. But as the rest of the world navigates the continuing impacts of the Covid-19 pandemic on their clinical trials enterprise, Australia is even better positioned to capitalise on our strengths and capabilities.

In this webinar we will hear from our Australian early phase trial sector experts working across healthy and patient cohorts and discuss how they have responded to the call for rapid vaccine and treatment research design, reviews, approvals, and implementation. We will also explore what best practice early phase trials in Australia looks like and how we can continue to grow this critically important element of our Australian clinical trials landscape.